| Y51.0 |
Anticholinesterase agents
|
| Y51.1 |
Other parasympathomimetics [cholinergics]
|
| Y51.2 |
Ganglionic blocking drugs, not elsewhere classified
|
| Y51.3 |
Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
Papaverine
|
| Y51.4 |
Predominantly alpha-adrenoreceptor agonists, not elsewhere classified
Metaraminol
|
| Y51.5 |
Predominantly beta-adrenoreceptor agonists, not elsewhere classified
Excludes:
- salbutamol ( Y55.6 )
|
| Y51.6 |
Alpha-adrenoreceptor antagonists, not elsewhere classified
Excludes:
- ergot alkaloids ( Y55.0 )
|
| Y51.7 |
Beta-adrenoreceptor antagonists, not elsewhere classified
|
| Y51.8 |
Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
Excludes:
- clonidine ( Y52.5 )
- guanethidine ( Y52.5 )
|
| Y51.9 |
Other and unspecified drugs primarily affecting the autonomic nervous system
Drugs stimulating both alpha- and beta-adrenoreceptors
|